CEO named for first UPMC Enterprises’ Translational Sciences spin-out

BlueSphere Bio, the first company to spin out of UPMC Enterprises’ Translational Sciences focus area, has named industry veteran David Apelian, MD, PhD, MBA, as the company’s CEO.

You Might Also Like…

more from the newsletter